Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Amelia Mendoza Rodriguez"'
Publikováno v:
Neurology Perspectives, Vol 4, Iss 3, Pp 100152- (2024)
Externí odkaz:
https://doaj.org/article/b78ee2373a0d48ee96f44c0bdae4928a
Autor:
José E. Meca-Lallana, José M. Prieto González, Ana B. Caminero Rodríguez, Javier Olascoaga Urtaza, Ana M. Alonso, Eduardo Durán Ferreras, Raúl Espinosa, Julio Dotor, Mercedes Romera, Adrián Ares Luque, Domingo Pérez Ruiz, Carmen Calles, Miguel A. Hernández, Miguel Hervás García, Amelia Mendoza Rodríguez, Yasmina Berdei Montero, Nieves Téllez, Nicolás Herrera Varó, Javier Sotoca, Silvia Presas-Rodríguez, Luis A. Querol Gutierrez, Mariona Hervás Pujol, Jordi Batlle Nadal, Gisela Martín Ozaeta, Laura Gubieras Lillo, Sergio Martínez Yélamos, Lluís Ramió-Torrentà, Javier Mallada Frechin, Antonio Belenguer Benavides, Francisco Gascón-Giménez, Bonaventura Casanova, Lamberto Landete Pascual, Leticia Berenguer, Laura Navarro, Montserrat Gómez Gutierrez, Carmen Durán, Ana Rodríguez Regal, Elena Álvarez, Daniel A. García-Estévez, Ana M. López Real, Miguel A. Llaneza González, María E. Marzo Sola, José L. Sánchez-Menoyo, Agustín Oterino, Ramón Villaverde González, Tamara Castillo-Triviño, Amaya Álvarez de Arcaya, Cristina Llarena
Publikováno v:
Neurology and Therapy, Vol 12, Iss 6, Pp 2177-2193 (2023)
Abstract Introduction Teriflunomide is a once-daily oral immunomodulator approved for relapsing forms of multiple sclerosis (MS) or relapsing–remitting multiple sclerosis (RRMS; depending on the local label), based on extensive evidence from clinic
Externí odkaz:
https://doaj.org/article/0d5e12714aa14ddbb6e6eadf49cbbed1
Autor:
Barbara C. Tilley, Eva Reiter, Klaus Seppi, Thomas Foltynie, Carlos Singer, Iciar Aviles-Olmos, Carmen Rodriguez-Blazquez, Michal Minár, Milan Grofik, Pille Taba, Vladimir Han, Henry Moore, Peter Valkovič, Alberto Bergareche-Yarza, Christopher G. Goetz, Eve Benchetrit, Matej Skorvanek, Graziella Mangone, Pablo Martinez-Martin, Anabel Chade, Anette Schrag, Werner Poewe, Norbert Kovács, Veronika Datieva, Amin Cervantes-Arriaga, Zuzana Gdovinova, Mario Alvarez-Sanchez, Nelida Garretto, Bernadette Pinter, Florence Cormier, Mari Muldmaa, Amelia Mendoza-Rodriguez, Juan Carlos Martínez-Castrillo, Oleg Levin, Jean-Christophe Corvol, Charline Benoit, Liis Kadastik-Eerme, David A. Gallagher, Tomoko Arakaki, Glenn T. Stebbins, Mayela Rodríguez-Violante, Monica M. Kurtis, Jing Huang, Karin Rallmann, Oscar S. Gershanik, Zsuzsanna Aschermann, Christoph Mueller
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
BACKGROUND: The Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) is a newly developed tool to assess Parkinson's disease (PD). Changes in scores on the scale over the course of PD, including increasing disease duration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e89622d6fbc285d13f908e27918b869
https://hdl.handle.net/20.500.12530/32508
https://hdl.handle.net/20.500.12530/32508
Autor:
Anabel Chade, Carlos Singer, Pablo Martinez-Martin, Barbara C. Tilley, Alberto Bergareche-Yarza, Christopher G. Goetz, Amelia Mendoza-Rodriguez, Nelida Garretto, Mario Alvarez-Sanchez, Henry Moore, Carmen Rodriguez-Blazquez, Juan Carlos Martínez-Castrillo, Maria João Forjaz, Tomoko Arakaki, Glenn T. Stebbins, Mayela Rodríguez-Violante, Monica M. Kurtis, Jing Huang, Oscar S. Gershanik
Publikováno v:
European journal of neurology. 21(3)
Background and purpose: The Movement Disorder Society sponsored version of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) is a comprehensive instrument for assessing Parkinson’s disease (PD). The present study was aimed at determining t
Autor:
Carlos Singer, Nelida Garretto, Oscar S. Gershanik, Amelia Mendoza-Rodriguez, Anabel Chade, Mario Alvarez-Sanchez, Juan Carlos Martínez-Castrillo, Tomoko Arakaki, Henry Moore, Jose Manuel Rojo-Abuin, Alberto Bergareche-Yarza, Christopher G. Goetz, Pablo Martinez-Martin, Barbara C. Tilley, Carmen Rodriguez-Blazquez, Glenn T. Stebbins, Mayela Rodríguez-Violante, Monica M. Kurtis, Jing Huang
Publikováno v:
Parkinsonismrelated disorders. 19(10)
Objective: To evaluate the motor experiences of daily living section of the Movement Disorders SocietyUnified Parkinson’s Disease Rating Scale (MDS-UPDRS M-EDL) for assessing disability in PD patients; to determine the association between disabilit
Autor:
José-Manuel Rojo-Abuín, Kallol Ray Chaudhuri, Pablo Martinez-Martin, Glenn T. Stebbins, Mayela Rodríguez-Violante, Monica M. Kurtis, Jing Huang, Tomoko Arakaki, Mario Alvarez-Sanchez, Henry Moore, Nelida Garretto, Amelia Mendoza-Rodriguez, Barbara C. Tilley, Anabel Chade, Juan Carlos Martínez-Castrillo, Carlos Singer, Carmen Rodriguez-Blazquez, Alberto Bergareche-Yarza, Christopher G. Goetz, Oscar S. Gershanik
Publikováno v:
European journal of neurology. 22(1)
Background and purpose Although Parkinson's disease (PD) is characterized by typical motor manifestations, non-motor symptoms (NMS) are an outstanding part of the disease. At present, several specific instruments for assessment of NMS are available.
Autor:
Mario Alvarez-Sanchez, Anabel Chade, Carlos Singer, Juan Carlos Martínez-Castrillo, Nelida Garretto, Glenn T. Stebbins, Mayela Rodríguez-Violante, Monica M. Kurtis, Jing Huang, Henry Moore, Tomoko Arakaki, Barbara C. Tilley, Amelia Mendoza-Rodriguez, Pablo Martinez-Martin, Alberto Bergareche-Yarza, Christopher G. Goetz, Carmen Rodriguez-Blazquez, Oscar S. Gershanik
Publikováno v:
Journal of neurology. 260(1)
The Movement Disorder Society-UPDRS (MDS-UPDRS) was published in 2008, showing satisfactory clinimetric results and has been proposed as the official benchmark scale for Parkinson's disease. The present study, based on the official MDS-UPDRS Spanish
Publikováno v:
The neurologist. 17(6 Suppl 1)
Experimental research has produced evidence in recent years underlying the beneficial effects that exercise can have in preventing and deceleration of the development of Parkinson disease. These beneficial effects are exerted through various mechanis